AI-generated summary
The authors compared intense pulsed light treatment with meibomian gland expression on both upper and lower eyelids against treatment of the lower eyelid alone in 115 patients with moderate-to-severe meibomian gland dysfunction. They report that tear break-up time, symptoms and meibum grade improved in both groups, and that the upper and lower treatment group had additional decreases in lid margin telangiectasia. No severe adverse effects were reported, and the authors describe the upper eyelid addition as safe with an additive benefit.
- Participants
- 115
- Who or what was studied
- Patients with moderate-to-severe meibomian gland dysfunction
- Limits stated in the abstract
- The abstract does not describe randomization or a control design beyond the two treatment groups, and the groups differed in size (75 versus 40).
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.